JEFFS ROGER
SEC CIK 1231615 · EDGAR
BoughtSold
Most active insiders at LQDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bloch Stephen M | Dir | — | $118.66M |
| 2 | JEFFS ROGER | CEO, Dir | — | $31.72M |
| 3 | Kaseta Michael | CFO, COO | — | $15.97M |
| 4 | Manning Paul B | Dir | — | $12.78M |
| 5 | Saggar Rajeev | Chief Medical Off | — | $11.16M |
| 6 | Adair Jason | Chief Business Off | — | $7.77M |
| 7 | Moomaw Scott | Chief Commercial Off | — | $5.52M |
| 8 | Rielly-Gauvin Katherine | Dir | — | $4.09M |
| 9 | Krepp Sarah | Chief Human Resource Off | — | $3.69M |
| 10 | SINGH RAMAN | Dir | — | $3.67M |
Transactions 50
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-14 20:07 | 2026-07-10 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | M - OptEx | — | +28.2K | 1.17M | +2% | — |
| DMT | 2026-07-14 20:07 | 2026-07-13 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale+OE | $71.51 | -35.2K | 1.13M | -3% | -$2.52M |
| MT | 2026-06-11 20:34 | 2026-06-10+ | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Dir | S - Sale | $247.65 | -572 | 58.4K | -1.0% | -$141.7K |
| D | 2026-06-10 21:49 | 2026-06-08 | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Dir | M - OptEx | — | +1,429 | 58.9K | +2% | — |
| TI | 2026-05-28 16:30 | 2026-05-27 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $62.18 | -6,428 | 1.04M | -0.6% | -$399.7K |
| MTI | 2026-05-26 18:16 | 2026-05-21+ | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $61.01 | -75.0K | 1.05M | -7% | -$4.58M |
| MTI | 2026-05-20 18:55 | 2026-05-18+ | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $58.91 | -75.0K | 1.12M | -6% | -$4.42M |
| MTI | 2026-05-15 18:59 | 2026-05-13+ | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $57.32 | -75.0K | 1.20M | -6% | -$4.30M |
| MTI | 2026-05-12 18:52 | 2026-05-08+ | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $45.89 | -75.0K | 1.27M | -6% | -$3.44M |
| MTI | 2026-05-07 18:19 | 2026-05-05+ | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $40.99 | -75.0K | 1.35M | -5% | -$3.07M |
| TI | 2026-04-21 16:30 | 2026-04-17 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $40.60 | -18.8K | 1.42M | -1% | -$765.0K |
| MTI | 2026-04-16 20:38 | 2026-04-14+ | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $40.21 | -53.3K | 1.44M | -4% | -$2.14M |
| DMT | 2026-04-14 17:05 | 2026-04-10 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | M - OptEx | — | +28.2K | 1.17M | +2% | — |
| DT | 2026-04-14 17:05 | 2026-04-13 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale+OE | $38.37 | -32.7K | 1.14M | -3% | -$1.26M |
| DTI | 2026-04-14 17:05 | 2026-04-10 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale+OE | $40.12 | -21.4K | 1.50M | -1% | -$859.9K |
| TI | 2026-04-13 17:47 | 2026-04-09 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $40.12 | -25.0K | 1.52M | -2% | -$1.00M |
| D | 2026-01-21 | 2026-01-16 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | A - Grant | $0.00 | +115.3K | 1.15M | +11% | $0 |
| D | 2026-01-13 | 2026-01-12 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale+OE | $37.43 | -66.6K | 1.04M | -6% | -$2.49M |
| DM | 2026-01-13 | 2026-01-09 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | M - OptEx | — | +71.2K | 1.05M | +7% | — |
| D | 2025-10-15 | 2025-10-13 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale+OE | $23.41 | -20.3K | 1.03M | -2% | -$474.3K |
| D | 2025-10-15 | 2025-10-10 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | M - OptEx | — | +13.8K | 1.05M | +1% | — |
| T | 2025-09-02 | 2025-09-02 | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Dir | S - Sale | $123.68 | -13.5K | 57.5K | -19% | -$1.67M |
| MT | 2025-08-29 | 2025-08-27+ | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Dir | S - Sale | $121.72 | -60.0K | 111.0K | -35% | -$7.30M |
| MT | 2025-08-26 | 2025-08-22+ | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Dir | S - Sale | $120.05 | -36.7K | 151.0K | -20% | -$4.41M |
| D | 2025-07-15 | 2025-07-14 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale+OE | $14.28 | -20.3K | 1.04M | -2% | -$289.2K |
| D | 2025-07-15 | 2025-07-11 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | M - OptEx | — | +13.8K | 1.06M | +1% | — |
| D | 2025-07-15 | 2025-07-11 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | M - OptEx | — | +13.8K | 1.06M | +1% | — |
| D | 2025-07-15 | 2025-07-14 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale+OE | $14.28 | -20.3K | 1.04M | -2% | -$289.2K |
| D | 2025-06-05 | 2025-06-03 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | M - OptEx | — | +69.2K | 1.08M | +7% | — |
| D | 2025-06-05 | 2025-06-04 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale+OE | $16.97 | -30.6K | 1.04M | -3% | -$519.5K |
| 2025-04-16 | 2025-04-14 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $13.57 | -14.1K | 1.01M | -1% | -$191.7K | |
| D | 2025-01-14 | 2025-01-11 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | A - Grant | $0.00 | +229.3K | 1.04M | +28% | $0 |
| D | 2025-01-14 | 2025-01-14 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $11.78 | -22.3K | 1.02M | -2% | -$263.2K |
| 2024-10-15 | 2024-10-14 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $11.11 | -8,053 | 812.2K | -1.0% | -$89.5K | |
| 2024-07-15 | 2024-07-12 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $12.53 | -8,053 | 818.9K | -1.0% | -$100.9K | |
| 2024-04-16 | 2024-04-12 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $14.58 | -8,360 | 827.0K | -1% | -$121.9K | |
| 2024-03-19 | 2024-03-18 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | S - Sale | $15.82 | -28.6K | 835.3K | -3% | -$452.2K | |
| DMT | 2024-03-15 | 2024-03-14+ | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Dir | S - Sale+OE | $69.84 | -32.3K | 120.8K | -21% | -$2.26M |
| DMT | 2024-03-15 | 2024-03-14+ | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Dir | M - OptEx | $24.44 | +32.3K | 137.7K | +31% | +$790.0K |
| D | 2024-01-16 | 2024-01-11 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | A - Grant | $0.00 | +221.3K | 862.1K | +35% | $0 |
| 2023-12-18 | 2023-12-14 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | P - Purchase | $7.16 | +139.7K | 640.8K | +28% | +$1.00M | |
| A | 2023-04-10 | 2022-08-31 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | A - Grant | $4.90 | +993 | 116.0K | +0.9% | +$4,866 |
| D | 2023-01-13 | 2023-01-11 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | A - Grant | $0.00 | +289.5K | 496.7K | +140% | $0 |
| D | 2023-01-05 | 2023-01-03 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | M - OptEx | — | +15.8K | 207.2K | +8% | — |
| D | 2022-10-04 | 2022-10-03 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | M - OptEx | — | +47.4K | 207.2K | +30% | — |
| 2022-09-07 | 2022-09-06 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | P - Purchase | $5.57 | +43.8K | 159.8K | +38% | +$244.1K | |
| 2022-09-01 | 2022-08-31 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | P - Purchase | $4.90 | +993 | 116.0K | +0.9% | +$4,866 | |
| I | 2022-05-25 | 2022-05-24 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | P - Purchase | $3.53 | +28.0K | 46.6K | +151% | +$98.8K |
| I | 2022-04-20 | 2022-03-31 | LQDA | Liquidia Corp | JEFFS ROGER | CEO, Dir | A - Grant | $0.00 | +154.2K | 1.54M | +11% | $0 |
| 2021-11-23 | 2021-11-19 | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Dir | P - Purchase | $37.30 | +3,950 | 120.8K | +3% | +$147.3K |
Purchase Sale Sale after option exercise All abbreviations